Year: 2018
Type: editorial
Abstract: Lung transplantation is the only potentially curative therapy for end-stage chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), and cystic fibrosis (CF), which together claim the lives of 150,000 patients each year in the USA (1). Yet less than 2,000 of these procedures are performed each year in the US due to donor availability, the need of specialized surgical and medical teams, and the overall unit costs that are approaching one million dollars.
Source: Journal of Thoracic Disease
Authors: Wa Xian, Frank McKeon
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W2798242891